Fighting Melanoma

[Ruslan Rust @rust_ruslan]

Eleven clinical trials that will shape medicine in 2026

Happy to see a lot of cell-based therapies!

https://t.co/23fKXbbp11

[Melanoma Research Foundation @CureMelanoma]

Introducing our new TIL Cell Therapy Journey: A Step-by-Step Guide for Melanoma Patients

We're proud to share this new resource to help patients understand every stage of Tumor Infiltrating Lymphocyte (TIL) Cell Therapy, an FDA-approved treatment option for people who have been previously treated for advanced melanoma. This roadmap offers clear guidance on what to expect, from your first conversation with your care team to follow-up after treatment.

Designed to empower patients and caregivers, the TIL Therapy roadmap outlines:

• What TIL therapy is and how doctors determine if it is right for you
• How your tumor sample is collected for TIL cell growth • What happens during the manufacturing and treatment phases
• Commonly reported side effects you and your care team can prepare for
• What follow-up care looks like and how long recovery may take

View the resource here: https://t.co/aaqmXLwDjb

[CancerTherapyAdvisor @CancerTherAdvsr]

#CancerRelatedCognitiveImpairment has received increasing attention in recent years, with a proliferation of studies aiming to characterize the scope of the problem and explore optimal assessment and intervention strategies. With @NLottick @YaleMed @LombardiCancer @UCLAHealthJCCC.

https://t.co/Yz2zYfHB1q

#CRCI

[Melanoma Research Foundation @CureMelanoma]

This week’s @US_FDA acceptance announcement of the resubmission of the Biologics License Application (BLA) for RPI gives hope to the many stage 4 #melanoma patients and their families that a new therapeutic option may become available soon and underscores the unmet medical need in patients with advanced melanoma who have progressed after PD 1 therapies—patients for whom established treatment options are limited.

Learn more - https://t.co/0TGsDOqwgs #ProgressIsPower

[Nature Reviews Drug Discovery @NatRevDrugDisc]

For readers interested in cancer therapies, this Review in the October issue discusses how metabolic modulators and dietary nutrients can improve the anticancer immune response and overcome drug resistance mechanisms
https://t.co/MOCCOorAF4
https://t.co/uf5zldDw4K

[CancerTherapyAdvisor @CancerTherAdvsr]

Therapeutic plasma exchange may allow patients with advanced melanoma to overcome immune checkpoint inhibitor resistance, according to research presented at #ESMO25 by Dr Jacob Orme of @MayoCancerCare.
#melsm #skcsm #ESMO25

https://t.co/R8nxayfXfB

[CURE Ocular Melanoma @MRFCureOM]

Be part of a global discussion on advancing care and hope for those affected by ocular melanoma (OM)!

Join the AOMA 2025 Virtual Summit on Nov 8, hosted by @MASC_Trials. Hear from international OM experts and patients.

RSVP: https://t.co/4Z5sBimRIz

[CancerTherapyAdvisor @CancerTherAdvsr]

#Medicaid expansion is associated with improvements in 5-year cause-specific survival and overall survival in #cancer patients. Published in @CD_AACR.
https://t.co/V3Q1faIvvj

[Melanoma Research Foundation @CureMelanoma]

As we continue to navigate the current federal government shutdown, the MRF remains committed to ensuring the melanoma community feels informed and empowered when exploring all options following a diagnosis — including access to clinical trials.

While some federally funded clinical trials are temporarily paused, not all trial sites will be impacted uniformly. If you are currently enrolled in a federally funded or oversight clinical trial (e.g., @NIH /@NCICancerCtrl run or sponsored trial), you will still be able to participate.

There is no impact to privately funded clinical trials and the MRF encourages the melanoma community to continue seeking clinical trial opportunities using our Clinical Trial Navigator — an easy-to-use tool that helps identify trials tailored to your diagnosis, ensuring access to the most up-to-date care options available.

Learn more here: https://t.co/1Vb85mi5kX

[AACR @AACR]

The fall issue of @CancerTodayMag features articles on the early integration of palliative care for blood cancer patients, the broadening of HER2 classification in breast cancer, and more. Read about the latest issue on the #AACRBlog: https://t.co/V2M4iOMR8o

[OncLive.com @OncLive]

Subcutaneous Pembrolizumab Shows Possibility of Providing Effective and Convenient Treatment in Oncology @HOGONC #medtwitter #oncology https://t.co/zrTMleKsZ3

[The Skin Cancer Foundation 👒 @SkinCancerOrg]

Hugh Jackman has been open about his battle with basal cell carcinoma. As he explains in the documentary "Conquering Skin Cancer," basal cell carcinomas are serious, and can cause scarring and other complications if ignored. #BCC #BasalCellCarcinoma

[Cancer Research Institute @CancerResearch]

Review the @US_FDA's most impactful oncology regulatory happenings during September, in @TargetedOnc's monthly roundup: https://t.co/Ld0UnRfV1C #FDAApproval #FDA #CancerResearch

[NIH @NIH]

NIH has released funding opportunities for three High Risk, High-Reward programs that support exceptionally creative researchers pursuing innovative, high-impact research. Apply before time runs out! https://t.co/iGUkUvOjEC

[Fighting Melanoma @FightMelanoma1]

Imagine a cancer vaccine you could grab off the shelf—not custom-built.
UF researchers are testing an mRNA shot that trains the immune system to hunt tumors of all kinds.
If human trials succeed, this could reshape oncology.
#CancerResearch #mRNA
https://t.co/2svQxo3Eo4

[Journal of Clinical Oncology @JCO_ASCO]

Nivolumab and Ipilimumab for Metastatic Castration-Resistant #ProstateCancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study.

Read full article. https://t.co/X3WPiOxwjp

[Professor Georgina Long AO (Bluesky @gvlongphdmd) @ProfGLongMIA]

I am so proud of leading the #Neoadjuvant NADINA phase 3 clinical trial (with Dutch colleague Prof Blank from @NKI_nl) and with the support of my amazing colleagues at @MelanomaAus.
Today, this #immunotherapy regimen (ipilimumab+nivolumab) is listed on PBS for ALL AUSSIES with clinically detected stage III melanoma because of this work.
Great for #melanoma and sets a benchmark for all #cancer.

We can cure cancer - we will get there.
I want to #cure the ‘third space’ - those not responding to standard immunotherapies, and still dying of melanoma and cancer.

Melanoma is the perfect model to understand this and make a difference.

@Sydney_Uni @syd_health

📸 Photo by Max Mason-Hubers

[Fighting Melanoma @FightMelanoma1]

Just submitted the final manuscript for Terminal Hope — from LA, where it all began.

Where I met Dr. Ribas.
Where stage IV melanoma met science.
Where hope took hold.

This story changed my life — and many others.

#TerminalHope #Melanoma #CancerResearch #UCLA #Survivorg

[Omid Hamid MD @OmidHamidMD]

Two decades here at The Angeles Clinic with @MarkFariesMD fighting #Melanoma at @CedarsSinai , @PMCSJH
#MelanomaAwarenessMonth no different. Real breakthroughs together with more #worktodo #clinicaltrials
[email protected]

[Melanoma Research Foundation @CureMelanoma]

With summer fast approaching, it is important to be aware of the #SunSafety best practices to keep you and your family protected all year long. During #MelanomaAwarenessMonth25, learn how to protect your skin from those UV rays through our Melanoma PPE Kit -https://t.co/j8zjmhyikq #MAM25 #GetNaked